The Patient and Community Advisory Committee (PCAC) comprises of individuals with lived experience with the Canadian health care system and who are familiar with issues in health care in Canada. PCAC...

Step 1: Review the Process and Templates We recommend that you review the general information on the CADTH Scientific Advice Program, including the Scientific Advice process, prior to submitting your...

2013 Award of Excellence Dr. Brian O’Rourke, President and CEO of the Canadian Agency for Drugs and Technologies in Health (CADTH), is pleased to announce that Christa Harstall, Director of Health...

The Health Technology Expert Review Panel (HTERP) is an advisory body to CADTH, convened to develop guidance and/or recommendations on non-drug health technologies to inform a range of stakeholders...

2010 Award of Excellence Dr. Brian O’Rourke, President and CEO of the Canadian Agency for Drugs and Technologies in Health (CADTH), is pleased to announce that Dr. Andreas Laupacis, MD, MSc, FRCPC, is...

All CADTH documents posted on the web site require the Adobe Acrobat Reader 8.0+. If a PDF document does not open or function correctly, please ensure that you have the most current freeware. You can...

CADTH is a national body that provides Canada’s federal, provincial and territorial health care decision makers with credible, impartial advice and evidence-based information about the effectiveness...

Meetings of the CADTH Canadian Drug Expert Committee (CDEC) may be held up to 12 times annually and are typically scheduled to occur on the third Wednesday of the month. Meetings are either held in...

Collection CADTH publishes a variety of health technology assessments and other materials, and makes them available on this website. Use of the website and material on the website is governed by these...

Careers at CADTH CADTH’s career opportunities are posted as they become available. Our job postings list core requirements and assets, which form the basis of our selection criteria. Please explain...